20
Emcure Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is IRON SUCROSE COMPLEX SOLUTION, with a corresponding US DMF Number 27958.
Remarkably, this DMF maintains an Active status since its submission on May 30, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 20, 2014, and payment made on June 03, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II